| UniProt ID | SPIN1_HUMAN | |
|---|---|---|
| UniProt AC | Q9Y657 | |
| Protein Name | Spindlin-1 | |
| Gene Name | SPIN1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 262 | |
| Subcellular Localization | Nucleus . Nucleus, nucleolus . | |
| Protein Description | Chromatin reader that specifically recognizes and binds histone H3 both trimethylated at 'Lys-4' and asymmetrically dimethylated at 'Arg-8' (H3K4me3 and H3R8me2a) and acts as an activator of Wnt signaling pathway downstream of PRMT2. In case of cancer, promotes cell cancer proliferation via activation of the Wnt signaling pathway. [PubMed: 24589551 Overexpression induces metaphase arrest and chromosomal instability. Localizes to active rDNA loci and promotes the expression of rRNA genes] | |
| Protein Sequence | MKTPFGKTPGQRSRADAGHAGVSANMMKKRTSHKKHRSSVGPSKPVSQPRRNIVGCRIQHGWKEGNGPVTQWKGTVLDQVPVNPSLYLIKYDGFDCVYGLELNKDERVSALEVLPDRVATSRISDAHLADTMIGKAVEHMFETEDGSKDEWRGMVLARAPVMNTWFYITYEKDPVLYMYQLLDDYKEGDLRIMPDSNDSPPAEREPGEVVDSLVGKQVEYAKEDGSKRTGMVIHQVEAKPSVYFIKFDDDFHIYVYDLVKTS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Methylation | ------MKTPFGKTP ------CCCCCCCCC | 65.98 | 30592611 | |
| 3 | Phosphorylation | -----MKTPFGKTPG -----CCCCCCCCCC | 23.66 | 21712546 | |
| 7 | Methylation | -MKTPFGKTPGQRSR -CCCCCCCCCCCCCC | 52.50 | 24129315 | |
| 7 | Acetylation | -MKTPFGKTPGQRSR -CCCCCCCCCCCCCC | 52.50 | 19608861 | |
| 7 | Sumoylation | -MKTPFGKTPGQRSR -CCCCCCCCCCCCCC | 52.50 | 28112733 | |
| 8 | Phosphorylation | MKTPFGKTPGQRSRA CCCCCCCCCCCCCCC | 32.79 | 28555341 | |
| 13 | Phosphorylation | GKTPGQRSRADAGHA CCCCCCCCCCCCCCC | 24.75 | 20068231 | |
| 23 | Phosphorylation | DAGHAGVSANMMKKR CCCCCCCCHHHHHHC | 17.01 | 20068231 | |
| 28 | Acetylation | GVSANMMKKRTSHKK CCCHHHHHHCCCCCC | 28.47 | 25953088 | |
| 28 | Sumoylation | GVSANMMKKRTSHKK CCCHHHHHHCCCCCC | 28.47 | 28112733 | |
| 29 | Acetylation | VSANMMKKRTSHKKH CCHHHHHHCCCCCCC | 42.91 | 26051181 | |
| 31 | Phosphorylation | ANMMKKRTSHKKHRS HHHHHHCCCCCCCHH | 44.02 | 20068231 | |
| 32 | Phosphorylation | NMMKKRTSHKKHRSS HHHHHCCCCCCCHHC | 37.02 | 20068231 | |
| 38 | Phosphorylation | TSHKKHRSSVGPSKP CCCCCCHHCCCCCCC | 29.15 | 23927012 | |
| 39 | Phosphorylation | SHKKHRSSVGPSKPV CCCCCHHCCCCCCCC | 30.93 | 23927012 | |
| 43 | Phosphorylation | HRSSVGPSKPVSQPR CHHCCCCCCCCCCCC | 43.60 | 20068231 | |
| 44 | Sumoylation | RSSVGPSKPVSQPRR HHCCCCCCCCCCCCC | 53.20 | 28112733 | |
| 44 | Ubiquitination | RSSVGPSKPVSQPRR HHCCCCCCCCCCCCC | 53.20 | - | |
| 44 | Acetylation | RSSVGPSKPVSQPRR HHCCCCCCCCCCCCC | 53.20 | 23236377 | |
| 47 | Phosphorylation | VGPSKPVSQPRRNIV CCCCCCCCCCCCCEE | 42.89 | 27251275 | |
| 63 | Ubiquitination | CRIQHGWKEGNGPVT EEECCCCCCCCCCCC | 61.41 | 21890473 | |
| 63 | Ubiquitination | CRIQHGWKEGNGPVT EEECCCCCCCCCCCC | 61.41 | 21890473 | |
| 63 | Ubiquitination | CRIQHGWKEGNGPVT EEECCCCCCCCCCCC | 61.41 | 21890473 | |
| 91 | Phosphorylation | PSLYLIKYDGFDCVY CCEEEEEECCCCEEE | 17.82 | 17053785 | |
| 98 | Phosphorylation | YDGFDCVYGLELNKD ECCCCEEEEEECCCC | 23.48 | 17053785 | |
| 104 | Ubiquitination | VYGLELNKDERVSAL EEEEECCCCCCEEEE | 73.85 | - | |
| 109 | Phosphorylation | LNKDERVSALEVLPD CCCCCCEEEEEECCC | 33.10 | 22258766 | |
| 120 | Phosphorylation | VLPDRVATSRISDAH ECCCHHHHCCCCHHH | 18.71 | 23401153 | |
| 121 | Phosphorylation | LPDRVATSRISDAHL CCCHHHHCCCCHHHH | 20.20 | 20068231 | |
| 124 | Phosphorylation | RVATSRISDAHLADT HHHHCCCCHHHHHHH | 27.86 | 29255136 | |
| 131 | Phosphorylation | SDAHLADTMIGKAVE CHHHHHHHHHHHHHH | 12.70 | 29396449 | |
| 177 | Phosphorylation | YEKDPVLYMYQLLDD EECCCEEEEEEECCH | 8.26 | 20049867 | |
| 179 | Phosphorylation | KDPVLYMYQLLDDYK CCCEEEEEEECCHHH | 5.18 | 20049867 | |
| 185 | Phosphorylation | MYQLLDDYKEGDLRI EEEECCHHHCCCEEE | 15.59 | 20049867 | |
| 186 | Ubiquitination | YQLLDDYKEGDLRIM EEECCHHHCCCEEEC | 63.31 | - | |
| 196 | Phosphorylation | DLRIMPDSNDSPPAE CEEECCCCCCCCCCC | 36.34 | 30266825 | |
| 199 | Phosphorylation | IMPDSNDSPPAEREP ECCCCCCCCCCCCCC | 36.71 | 29255136 | |
| 212 | Phosphorylation | EPGEVVDSLVGKQVE CCCCHHHHHCCCEEE | 17.22 | 30108239 | |
| 216 | Ubiquitination | VVDSLVGKQVEYAKE HHHHHCCCEEEEECC | 43.63 | - | |
| 222 | Acetylation | GKQVEYAKEDGSKRT CCEEEEECCCCCCCC | 56.27 | 155779 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SPIN1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SPIN1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| ANM6_HUMAN | PRMT6 | physical | 23455924 | |
| SPIN4_HUMAN | SPIN4 | physical | 26186194 | |
| SP16H_HUMAN | SUPT16H | physical | 26186194 | |
| BCLF1_HUMAN | BCLAF1 | physical | 26186194 | |
| TR150_HUMAN | THRAP3 | physical | 26186194 | |
| CGBP1_HUMAN | CGGBP1 | physical | 26186194 | |
| SSRP1_HUMAN | SSRP1 | physical | 26186194 | |
| YRDC_HUMAN | YRDC | physical | 26186194 | |
| CK084_HUMAN | C11orf84 | physical | 26186194 | |
| MCM2_HUMAN | MCM2 | physical | 26186194 | |
| ZGPAT_HUMAN | ZGPAT | physical | 26186194 | |
| SF3A3_HUMAN | SF3A3 | physical | 26186194 | |
| SCNM1_HUMAN | SCNM1 | physical | 26186194 | |
| TOPRS_HUMAN | TOPORS | physical | 26186194 | |
| PAX3_HUMAN | PAX3 | physical | 26186194 | |
| CK084_HUMAN | C11orf84 | physical | 28514442 | |
| CGBP1_HUMAN | CGGBP1 | physical | 28514442 | |
| YRDC_HUMAN | YRDC | physical | 28514442 | |
| TOPRS_HUMAN | TOPORS | physical | 28514442 | |
| SCNM1_HUMAN | SCNM1 | physical | 28514442 | |
| ZGPAT_HUMAN | ZGPAT | physical | 28514442 | |
| PAX3_HUMAN | PAX3 | physical | 28514442 | |
| SF3A3_HUMAN | SF3A3 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-7, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-124 AND SER-199, ANDMASS SPECTROMETRY. | |
| "Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-38 AND SER-39, AND MASSSPECTROMETRY. | |
| "Tyrosine phosphorylated Par3 regulates epithelial tight junctionassembly promoted by EGFR signaling."; Wang Y., Du D., Fang L., Yang G., Zhang C., Zeng R., Ullrich A.,Lottspeich F., Chen Z.; EMBO J. 25:5058-5070(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-91 AND TYR-98, AND MASSSPECTROMETRY. | |